TrialCNS neuroscience & therapeutics2024

A randomized, double-blind, placebo-controlled, dose-escalating phase IIa trial to evaluate the safety, tolerability, efficacy, and pharmacokinetics of multiple oral doses of Pynegabine tablets as add-on therapy in patients with focal epilepsy.

Shan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.